EdgePoint Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

EdgePoint Investment Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$943M	Buy	1,918,997 +533,848	+39%	+$290M	7.56%	2
2025 Q4	$803M	Sell	1,385,149 -3,513	-0.3%	-$1.99M	6.59%	5
2025 Q3	$674M	Buy	1,388,662 +65,597	+5%	+$30.5M	5.03%	10
2025 Q2	$536M	Buy	1,323,065 +977,127	+282%	+$409M	4.06%	14
2025 Q1	$172M	Buy	+345,938	New	+$187M	1.39%	22
2016 Q2	–	Sell	-686,275	Closed	-$97.2M	–	44
2016 Q1	$97.2M	Buy	686,275 +238,631	+53%	+$32M	1.68%	21
2015 Q4	$63.5M	Buy	+447,644	New	+$59.7M	1.23%	24

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EdgePoint Investment Group's TMO Position: Q1 2026 in Review

EdgePoint Investment Group increased its Thermo Fisher Scientific (TMO) stake by 39% in Q1 2026, buying an estimated $290M and bringing the position to 1,918,997 shares worth $943M. The position accounts for 7.56% of the portfolio, ranked #2.

EdgePoint Investment Group first reported a position in TMO in Q4 2015 and has held it in 7 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

EdgePoint Investment Group held 1,918,997 shares of Thermo Fisher Scientific worth $943M as of Q1 2026.
EdgePoint Investment Group bought 533,848 Thermo Fisher Scientific shares in Q1 2026, an estimated $290M.
Thermo Fisher Scientific made up 7.56% of EdgePoint Investment Group's portfolio in Q1 2026, its #2 holding.
EdgePoint Investment Group first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 7 quarters since.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on EdgePoint Investment Group's 13F filing for Q1 2026, filed 15 May 2026.